Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Duffy

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
JACC. Heart Failure|August 18, 2020
Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF TrialDavid D Berg, Eugene Braunwald, Adam D DeVore, et al.
American Heart Journal|April 15, 2018
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trialEric J Velazquez, David A Morrow, Adam D DeVore, et al.
Circulation|April 9, 2019
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF TrialDavid A Morrow, Eric J Velazquez, Adam D DeVore, et al.
Trauma Surgery & Acute Care Open|September 25, 2018
A pilot study assessing the spiritual, emotional, physical/environmental, and physiological needs of mechanically ventilated surgical intensive care unit patients via eye tracking devices, head nodding, and communication boardsErin I Duffy, Jonah Garry, Lillian Talbot, et al.
JACC. Heart Failure|September 13, 2020
Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF TrialCecilia Berardi, Eugene Braunwald, David A Morrow, et al.
Journal of the American College of Cardiology|November 16, 2019
Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes MellitusMuthiah Vaduganathan, Gregg C Fonarow, Stephen J Greene, et al.
Circulation. Heart Failure|June 26, 2020
Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HFAdam D DeVore, Anne S Hellkamp, Laine Thomas, et al.
JACC. Heart Failure|December 14, 2020
Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction PatientsPratyaksh K Srivastava, Adam D DeVore, Anne S Hellkamp, et al.
Journal of the American Heart Association|June 14, 2018
Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF TrialAdam D DeVore, Xiaojuan Mi, Laine Thomas, et al.
JAMA Cardiology|March 24, 2021
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection FractionStephen J Greene, Javed Butler, John A Spertus, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
JACC. Heart Failure|August 18, 2020
Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF TrialDavid D Berg, Eugene Braunwald, Adam D DeVore, et al.
American Heart Journal|April 15, 2018
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trialEric J Velazquez, David A Morrow, Adam D DeVore, et al.
Circulation|April 9, 2019
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF TrialDavid A Morrow, Eric J Velazquez, Adam D DeVore, et al.
Trauma Surgery & Acute Care Open|September 25, 2018
A pilot study assessing the spiritual, emotional, physical/environmental, and physiological needs of mechanically ventilated surgical intensive care unit patients via eye tracking devices, head nodding, and communication boardsErin I Duffy, Jonah Garry, Lillian Talbot, et al.
JACC. Heart Failure|September 13, 2020
Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF TrialCecilia Berardi, Eugene Braunwald, David A Morrow, et al.
Journal of the American College of Cardiology|November 16, 2019
Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes MellitusMuthiah Vaduganathan, Gregg C Fonarow, Stephen J Greene, et al.
Circulation. Heart Failure|June 26, 2020
Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HFAdam D DeVore, Anne S Hellkamp, Laine Thomas, et al.
JACC. Heart Failure|December 14, 2020
Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction PatientsPratyaksh K Srivastava, Adam D DeVore, Anne S Hellkamp, et al.
Journal of the American Heart Association|June 14, 2018
Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF TrialAdam D DeVore, Xiaojuan Mi, Laine Thomas, et al.
JAMA Cardiology|March 24, 2021
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection FractionStephen J Greene, Javed Butler, John A Spertus, et al.
Pageof 5